INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.1B -8.03M -10.89M -6.65M
Depreciation & Amortization
622.28M 200.89K 306.32K 166.08K
Stock-Based Compensation
1.25B 1.39M 2.22M 2.71M
Other Working Capital
n/a -388.67K 351.47K -3.67M
Other Non-Cash Items
n/a 1.21M 505.43K 1.19M
Deferred Income Tax
n/a -1.95K 810.00 168.42K
Change in Working Capital
n/a 471.7K 1.25M -3.61M
Operating Cash Flow
-2.97B -4.76M -6.6M -6.03M
Capital Expenditures
n/a -444.72K -12.73K -454.65K
Cash Acquisitions
n/a -2.05M -68.49K -1.7M
Purchase of Investments
n/a -8.45K -68.49K -1.7M
Sales Maturities Of Investments
n/a 16.89K 138.92K 3.44M
Other Investing Acitivies
363.89M -8.45K -70.43K -1.74M
Investing Cash Flow
363.89M -2.49M -81.22K -2.15M
Debt Repayment
n/a 1.66M 800K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-250.63M n/a n/a n/a
Other Financial Acitivies
3.2B 25.43K 800K 3.77M
Financial Cash Flow
3.12B 7.39M 1.09M 3.77M
Net Cash Flow
508.97M 142.29K -5.59M -4.41M
Free Cash Flow
-2.97B -5.2M -6.62M -6.48M